SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-May-22 4:28 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 18-May-22 | Payment of Exercise | 5,447 | $1.40 | $7,625.80 | (4%) 141.59K to 136.14K | |
26-Jan-22 4:31 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 24-Jan-22 | Payment of Exercise | 9,607 | $1.13 | $10,855.90 | (6%) 151.19K to 141.59K | (2%) |
20-May-21 4:05 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 18-May-21 | Payment of Exercise | 6,467 | $3.12 | $20,177.00 | (4%) 157.66K to 151.19K | 2% |
26-Jan-21 7:01 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 24-Jan-21 | Payment of Exercise | 9,597 | $4.46 | $42,802.60 | (6%) 167.26K to 157.66K | (3%) |
20-May-20 9:48 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 18-May-20 | Grant | 71,550 | -- | -- | 75% 95.71K to 167.26K | |
30-Jan-20 5:38 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 28-Jan-20 | Payment of Exercise | 9,140 | $7.00 | $63,980.00 | (9%) 104.85K to 95.71K | |
28-Jan-19 5:50 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 24-Jan-19 | Grant | 104,849 | -- | -- | 100% 0 to 104.85K |